Onychomycosis Market Revenue, Company Profile, Key Trend Analysis & Forecast Till 2027

 


The Global Onychomycosis Market is expected to register a CAGR of 6.28% during the forecast period with a market value of USD 7,912.5 Million till 2025. Onychomycosis is a general term used to denote any fungal nail infection. Factors such as the surging diabetic patient population, rising per capita healthcare expenditure coupled with the rising occurrences of onychomycosis, are anticipated to fuel the growth of the global onychomycosis market. However, the lack of awareness about onychomycosis and the side-effects associated with onychomycosis treatment drugs is likely to hamper the market growth.

Segment Analysis

The global onychomycosis market, by type, has been divided into distal subungual onychomycosis (DSO), white superficial onychomycosis (WSO), proximal subungual onychomycosis (PSO), candida onychomycosis, and others. On the basis of treatment type, the global onychomycosis market has been divided into drug treatment, topical therapy, and others. The global onychomycosis market, by distribution channel, has been segmented into hospital pharmacies, retail pharmacies, and others.

Regional Analysis

The global onychomycosis market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to hold the largest share of the global onychomycosis market. The increasing incidence rate of onychomycosis, presence of healthcare companies, developed healthcare infrastructure, great per capita healthcare spending, and high funding for R&D projects in the US and Canada are likely to support the dominance of the Americas during the forecast period.

The Europe market established substantial growth in the market due to increasing elderly population and the growing burden of diabetes, and growing incidence rates of onychomycosis in countries such as UK, Germany, France, and Spain.

Asia-Pacific is estimated to be the fastest-growing region in the global market due to huge patient population, rapidly developing medical technology, and growing disposable income.

The onychomycosis market in the Middle East and African region is expected to grow due to the rising awareness about onychomycosis coupled increasing collaborations and agreements to commercialize onychomycosis products.

Market Players

MRFR recognizes the following companies as the key players in the global onychomycosis market— Novartis AG (Switzerland), Bausch Health Sciences (Canada), Pfizer, Inc. (US), Galderma Laboratories (Switzerland), Moberg Pharma AB (Sweden), Kaken Pharmaceutical Co., Ltd (Japan), Medimetriks Pharmaceuticals, Inc. (US), Dr. Reddy’s Laboratories Ltd (India), Merz Pharma (Germany), GlaxoSmithKline plc (UK), Johnson & Johnson Services, Inc. (US), and Taro Pharmaceuticals Industries Ltd (Israel).

Key Findings of the Study

  • The Global Onychomycosis Market is estimated to grow at USD 7,912.5 Million by 2025 at a CAGR of 6.28% during the assessment period
  • Americas accounted for the largest share of the global market due to the presence of key market players and an increasing patient population in the US and Canada
  • Based on type, the distal subungual onychomycosis segment accounted for the largest market share of 3% in 2018
  • Based on treatment type, the drug treatment segment accounted for the largest market share of 4% in 2018
  • On the basis of the distribution channel, the hospital pharmacies segment accounted for the largest market share of 6% in 2018

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Doxorubicin Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the  doxorubicin market  are surge in geriatric population, rising prevalence of different types of cancer, increasing awareness for cancer treatment. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities. The various side effects, cost containment policies by various governments, stringent regulatory environment for product approval, are likely to hinder market growth during the forecast period. Regional Analysis The American market is expected to dominate the global doxorubicin market during the forecast period due to the presence of major manufacturers, increase in number of cancer cases, awareness ...
Read more

Chromatography Software Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
According to MRFR analysis, the global  Chromatography Software Market  is expected to register a CAGR of ~8.1% from 2022 to 2030 and hold a value of USD 15,330 million by 2030. Chromatography software is the gadget that allows chromatography-based analysis. This software system organizes and manages data from chromatography instruments, records and processes it, and generates chromatograms and reports. Data processing, instrument control, and database management are automated using this chromatography data software. Chromatography informatics solutions are available in various formats, from integrated to automated independent software platforms. These tools are employed in multiple sectors, including materials science, drug development, and forensics. The growing demand for chromatography applications in different fields, surge in the utilization of chromatography techniques in R&D activities across various industries such as the pharmaceutical industry and increasing tec...
Read more

Orthokeratology Lens Market Revenue Trends, Company Profiles, Revenue Share Analysis Till 2030

Image
The   Orthokeratology Lens Market   is expected to reach USD 3,900.8 Million by 2030 at 7.8% CAGR during the forecast period 2022-2030. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision. The increasing advancements in the field of ophthalmology over the past couple of decades, low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is anticipated to drive the market growth. However, the risk associated with orthokeratology and availability of alternative treatment methods is likely to hamper the market growth. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/8218 Segment Analysis The global ortho...
Read more